Guangdong AMS Pharmaceutical

Guangdong AMS Positron Technology (also known as Guangdong AMS Pharmaceutical) is a specialized Chinese radiopharmaceutical company based in Dongguan, Guangdong. The company focuses on the development, manufacturing, and distribution of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. It operates state-of-the-art manufacturing facilities equipped with medical cyclotrons to produce diagnostic tracers such as 18F-FDG, 18F-FAPI-04, and 18F-AlF-NOTA-Octreotide. As a key regional hub, the company plays a vital role in supplying clinical nuclear medicine products to major hospitals across Southern China. Guangdong AMS Positron Technology operates as a wholly-owned subsidiary of Dongcheng AMS (Nanjing Jiangyuan Andike), which is under the umbrella of the publicly traded Yantai Dongcheng Pharmaceutical Group.